Profile of Adverse Events with Duloxetine Treatment: A Pooled Analysis of Placebo-Controlled Studies

By Brunton Stephen  

Drug Safety, Vol. 33, Iss. 5, 2010-05 ,pp. : 393-407

Adis International

Access to resources Recommend Favorite

Effects of the Concomitant Administration of Tamsulosin (0.8 mg/day) on the Pharmacokinetic and Safety Profile of Theophylline (5 mg/kg): a Placebo-controlled Evaluation

By Miyazawa Y   Starkey LP   Forrest A   Schentag JJ   Kamimura H   Swarz H   Ito Y  

The Journal of International Medical Research, Vol. 30, Iss. 1, 2002-01 ,pp. : 34-43

Field House Publishing

Access to resources Recommend Favorite

The failure of placebo-controlled studies

By Montgomery S.A.  

European Neuropsychopharmacology, Vol. 9, Iss. 3, 1999-03 ,pp. : 271-276

Elsevier

Access to resources Recommend Favorite

Efficacy, Safety and Pharmacokinetics of Indacaterol in Caucasian and Japanese Patients with Chronic Obstructive Pulmonary Disease: A Comparison of Data from Two Randomized, Placebo-Controlled Studies

By Hosoe Motoi  

Clinical Drug Investigation, Vol. 31, Iss. 4, 2011-04 ,pp. : 247-255

Adis International

Access to resources Recommend Favorite

The hepatic safety profile of duloxetine: a review

By McIntyre Roger S   Panjwani Zilomi D   Nguyen Ha T   Woldeyohannes Hanna O   Alsuwaidan Mohammad   Soczynska Joanna K   Lourenco Maria T   Konarski Jakub Z   Kennedy Sidney H  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 3, 2008-03 ,pp. : 281-285

Informa Healthcare

Access to resources Recommend Favorite